Is Neurocrine Biosciences, Inc. overvalued?

Neurocrine Biosciences, Inc. (NBIX) looks undervalued — trading about 58% below its fair value.

Undervalued

Price

$152.94

Fair value

$240.96

Current P/E

22.1

Normal P/E

34.8

Market cap

$15.38B

Dividend yield

0.0%

Return on equity

21.1%

Sector

Healthcare

Fair value compares NBIX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks